Skip to content
Parakho

Bajaj Healthcare Ltd

NSE BAJAJHCAREBSE 539872

Q2 FY27, unaudited

Revenue
₹175.90 Cr
Profit after tax
₹14.09 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ2 FY27vs a year ago6M FY27
Revenue from operations175.90+18.92%341.53
Other income0.89−46.01%1.70
Total income176.79+18.20%343.24
Employee benefit expense19.11+15.77%36.58
Finance costs5.98+7.49%12.07
Depreciation & amortisation7.65+8.01%14.66
Total expenses158.32+18.50%308.30
Profit before tax18.48+15.75%34.93
Tax expense4.10+16.58%6.66
Profit after tax14.09+26.87%27.79
Total comprehensive income14.32+26.76%28.24
Earnings per share
Earnings per share, basic₹4.19₹8.26
Earnings per share, diluted₹4.18₹8.24

Q2 FY27 and 6M FY27 — unaudited, from the company’s filing with NSE. Source

Q2 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

Q2 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Bajaj Healthcare reported Q1 FY27 revenue of Rs 165.6 crore, up 11.3% year-on-year, with EBITDA margin expanding to 17.8%. Management described progress on new manufacturing facilities for peptides and oncology APIs, first-mover regulatory approvals in CNS therapy, and a reduction in debt-to-equity ratio. Domestic API business grew 27% year-on-year and was highlighted as the key growth driver for the quarter.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Filings

12 shown · 46 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 12 Oct 2026.